These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b. Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223 [TBL] [Abstract][Full Text] [Related]
23. The regression time of ocular surface squamous neoplasia using topical interferon alfa-2b does not depend on the initial tumor size. Vilaltella M; Huerva V Arq Bras Oftalmol; 2021; 85(2):109-114. PubMed ID: 34431893 [TBL] [Abstract][Full Text] [Related]
24. Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population. Kim BH; Kim MK; Wee WR; Oh JY Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2569-73. PubMed ID: 24006080 [TBL] [Abstract][Full Text] [Related]
25. Primary treatment of ocular surface squamous neoplasia with topical interferon alpha-2b: Comparative analysis of outcomes based on original tumor configuration. Shields CL; Constantinescu AB; Paulose SA; Yaghy A; Dalvin LA; Shields JA; Lally SE Indian J Ophthalmol; 2021 Mar; 69(3):563-567. PubMed ID: 33595473 [TBL] [Abstract][Full Text] [Related]
26. [Two cases of conjunctival malignant melanoma treated with topical interferon alpha-2b drop as an adjuvant therapy]. Kase S; Ishijima K; Noda M; Ishida S Nippon Ganka Gakkai Zasshi; 2011 Nov; 115(11):1043-7. PubMed ID: 22171510 [TBL] [Abstract][Full Text] [Related]
27. Interferon Alfa-2b for Pigmented Ocular Surface Squamous Neoplasia: A Report of 8 Lesions. Kaliki S; Sharma A; Vempuluru VS Cornea; 2021 Feb; 40(2):142-146. PubMed ID: 32355112 [TBL] [Abstract][Full Text] [Related]
28. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up. Krilis M; Tsang H; Coroneo M Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of topical 5-fluorouracil in conjunctival intraepithelial neoplasia refractory to interferon alpha-2b. Pérez-García P; Burgos-Blasco B; Gómez-Calleja V; Vidal-Villegas B; Méndez-Fernández R; Gegúndez-Fernández JA; Díaz-Valle D J Oncol Pharm Pract; 2023 Jun; 29(4):975-979. PubMed ID: 36131486 [TBL] [Abstract][Full Text] [Related]
30. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications. Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578 [TBL] [Abstract][Full Text] [Related]
31. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control]. Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009 [TBL] [Abstract][Full Text] [Related]
32. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. Sturges A; Butt AL; Lai JE; Chodosh J Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690 [TBL] [Abstract][Full Text] [Related]
33. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex. Finger PT; Sedeek RW; Chin KJ Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257 [TBL] [Abstract][Full Text] [Related]
34. Efficacy, safety and cost-effectiveness of 5-fluorouracil versus interferon α-2b as adjuvant therapy after surgery in ocular surface squamous neoplasia in a southern European tertiary hospital. San Román Llorens JJ; Fernández-Gurria M; Artaechevarria Artieda J; Alejandre Alba N; García Sandoval B; Jiménez-Alfaro Morote I Int Ophthalmol; 2024 Apr; 44(1):184. PubMed ID: 38630143 [TBL] [Abstract][Full Text] [Related]
35. Immunoreduction of locally advanced orbito-conjunctival squamous cell carcinoma with intraorbital interferon alpha-2b injection: a globe saving approach. Meel R; Dhiman R; Sen S; Sharma S Clin Exp Ophthalmol; 2018 Jan; 46(1):87-88. PubMed ID: 28570760 [No Abstract] [Full Text] [Related]
36. Topical interferon alpha-2b for a giant ocular surface squamous neoplasia: 7 years of follow-up after complete remission. Galvis V; Moreno NJ; Tello A; Carreño NI BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33608345 [TBL] [Abstract][Full Text] [Related]
37. Long-term outcome of amniotic membrane transplantation combined with mitomycin C for conjunctival reconstruction after ocular surface squamous neoplasia excision. Hanada K; Nishikawa N; Miyokawa N; Yoshida A Int Ophthalmol; 2017 Feb; 37(1):71-78. PubMed ID: 27061904 [TBL] [Abstract][Full Text] [Related]
38. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification. Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of a short-term topical interferon α-2b treatment for histologically proven melanoma and primary acquired melanosis with atypia. Garip A; Schaumberger MM; Wolf A; Herold TR; Miller CV; Klingenstein A; Schebitz-Walter K; Hintschich CR Orbit; 2016; 35(1):29-34. PubMed ID: 26636727 [TBL] [Abstract][Full Text] [Related]